Literature DB >> 34997419

ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.

Takaaki Konishi1,2, Michimasa Fujiogi3,4, Masahiko Tanabe5, Yasuyuki Seto5, Hideo Yasunaga3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34997419     DOI： 10.1245/s10434-021-11277-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.

Authors:  Sibylle Loibl; Gunter von Minckwitz; Günther Raab; Jens-Uwe Blohmer; Serban Dan Costa; Bernd Gerber; Holger Eidtmann; Simone Petrich; Jörn Hilfrich; Christian Jackisch; Andreas du Bois; Manfred Kaufmann
Journal:  Ann Surg Oncol       Date:  2006-09-17       Impact factor: 5.344

2.  Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.

Authors:  C Omarini; G Guaitoli; S Noventa; A Andreotti; A Gambini; E Palma; S Papi; G Tazzioli; S Balduzzi; M Dominici; S Cascinu; F Piacentini
Journal:  Eur J Surg Oncol       Date:  2016-10-20       Impact factor: 4.424

3.  Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review.

Authors:  Jenny Huang; Lisa Barbera; Melissa Brouwers; George Browman; William J Mackillop
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

4.  Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.

Authors:  Rachel A Sanford; Xiudong Lei; Carlos H Barcenas; Elizabeth A Mittendorf; Abigail S Caudle; Vicente Valero; Debu Tripathy; Sharon H Giordano; Mariana Chavez-MacGregor
Journal:  Ann Surg Oncol       Date:  2015-12-17       Impact factor: 5.344
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.